世界の注射用懸濁液ブデソニド市場予測 2021年-2026年

◆英語タイトル:Global Injectable Suspension Budesonide Market Growth 2021-2026
◆商品コード:LPI21JL16667
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月
◆ページ数:106
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
LP Information社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

LPインフォメーション社の「注射用懸濁液ブデソニドの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、0.5mg、1mgなど、用途別には、呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他などにセグメント区分してまとめました。注射用懸濁液ブデソニドのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・注射用懸濁液ブデソニドの世界市場概要(サマリー)
・注射用懸濁液ブデソニドの企業別販売量・売上
・注射用懸濁液ブデソニドの企業別市場シェア
・注射用懸濁液ブデソニドの世界市場規模 2016年-2021年:種類別(0.5mg、1mg)
・注射用懸濁液ブデソニドの世界市場規模 2016年-2021年:用途別(呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他)
・注射用懸濁液ブデソニドの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・注射用懸濁液ブデソニドのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・注射用懸濁液ブデソニドのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・注射用懸濁液ブデソニドの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・注射用懸濁液ブデソニド市場の成長要因・課題・動向
・注射用懸濁液ブデソニドの世界市場予測 2021年-2026年
・注射用懸濁液ブデソニドの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・注射用懸濁液ブデソニドのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・注射用懸濁液ブデソニドのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・注射用懸濁液ブデソニドの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・注射用懸濁液ブデソニドの世界市場予測:種類別(0.5mg、1mg)
・注射用懸濁液ブデソニドの世界市場予測:用途別(呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Injectable Suspension Budesonide will have significant change from previous year. By the most conservative estimates of global Injectable Suspension Budesonide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Injectable Suspension Budesonide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Suspension Budesonide market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
0.5mg
1mg

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injectable Suspension Budesonide Consumption 2016-2026
2.1.2 Injectable Suspension Budesonide Consumption CAGR by Region
2.2 Injectable Suspension Budesonide Segment by Type
2.2.1 0.5mg
2.2.2 1mg
2.3 Injectable Suspension Budesonide Sales by Type
2.3.1 Global Injectable Suspension Budesonide Sales Market Share by Type (2016-2021)
2.3.2 Global Injectable Suspension Budesonide Revenue and Market Share by Type (2016-2021)
2.3.3 Global Injectable Suspension Budesonide Sale Price by Type (2016-2021)
2.4 Injectable Suspension Budesonide Segment by Application
2.4.1 Respiratory Disease Treatment
2.4.2 Nose Disease Treatment
2.4.3 Inflammatory Bowel Disease Treatment
2.4.4 Other
2.5 Injectable Suspension Budesonide Sales by Application
2.5.1 Global Injectable Suspension Budesonide Sale Market Share by Application (2016-2021)
2.5.2 Global Injectable Suspension Budesonide Revenue and Market Share by Application (2016-2021)
2.5.3 Global Injectable Suspension Budesonide Sale Price by Application (2016-2021)

3 Global Injectable Suspension Budesonide by Company
3.1 Global Injectable Suspension Budesonide Sales Market Share by Company
3.1.1 Global Injectable Suspension Budesonide Sales by Company (2019-2021)
3.1.2 Global Injectable Suspension Budesonide Sales Market Share by Company (2019-2021)
3.2 Global Injectable Suspension Budesonide Revenue Market Share by Company
3.2.1 Global Injectable Suspension Budesonide Revenue by Company (2019-2021)
3.2.2 Global Injectable Suspension Budesonide Revenue Market Share by Company (2019-2021)
3.3 Global Injectable Suspension Budesonide Sale Price by Company
3.4 Global Manufacturers Injectable Suspension Budesonide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable Suspension Budesonide Product Location Distribution
3.4.2 Players Injectable Suspension Budesonide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Injectable Suspension Budesonide by Region
4.1 Global Injectable Suspension Budesonide by Region
4.1.1 Global Injectable Suspension Budesonide Sales by Region
4.1.2 Global Injectable Suspension Budesonide Revenue by Region
4.2 Americas Injectable Suspension Budesonide Sales Growth
4.3 APAC Injectable Suspension Budesonide Sales Growth
4.4 Europe Injectable Suspension Budesonide Sales Growth
4.5 Middle East & Africa Injectable Suspension Budesonide Sales Growth

5 Americas
5.1 Americas Injectable Suspension Budesonide Sales by Country
5.1.1 Americas Injectable Suspension Budesonide Sales by Country (2016-2021)
5.1.2 Americas Injectable Suspension Budesonide Revenue by Country (2016-2021)
5.2 Americas Injectable Suspension Budesonide Sales by Type
5.3 Americas Injectable Suspension Budesonide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Injectable Suspension Budesonide Sales by Region
6.1.1 APAC Injectable Suspension Budesonide Sales by Region (2016-2021)
6.1.2 APAC Injectable Suspension Budesonide Revenue by Region (2016-2021)
6.2 APAC Injectable Suspension Budesonide Sales by Type
6.3 APAC Injectable Suspension Budesonide Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Injectable Suspension Budesonide by Country
7.1.1 Europe Injectable Suspension Budesonide Sales by Country (2016-2021)
7.1.2 Europe Injectable Suspension Budesonide Revenue by Country (2016-2021)
7.2 Europe Injectable Suspension Budesonide Sales by Type
7.3 Europe Injectable Suspension Budesonide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Injectable Suspension Budesonide by Country
8.1.1 Middle East & Africa Injectable Suspension Budesonide Sales by Country (2016-2021)
8.1.2 Middle East & Africa Injectable Suspension Budesonide Revenue by Country (2016-2021)
8.2 Middle East & Africa Injectable Suspension Budesonide Sales by Type
8.3 Middle East & Africa Injectable Suspension Budesonide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Injectable Suspension Budesonide Distributors
10.3 Injectable Suspension Budesonide Customer

11 Global Injectable Suspension Budesonide Market Forecast
11.1 Global Injectable Suspension Budesonide Forecast by Region
11.1.1 Global Injectable Suspension Budesonide Forecast by Regions (2021-2026)
11.2.2 Global Injectable Suspension Budesonide Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Injectable Suspension Budesonide Forecast by Type
11.7 Global Injectable Suspension Budesonide Forecast by Application

12 Key Players Analysis
12.1 AstraZeneca
12.1.1 AstraZeneca Company Information
12.1.2 AstraZeneca Injectable Suspension Budesonide Product Offered
12.1.3 AstraZeneca Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AstraZeneca Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Teva
12.2.1 Teva Company Information
12.2.2 Teva Injectable Suspension Budesonide Product Offered
12.2.3 Teva Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Teva Main Business Overview
12.2.5 Teva Latest Developments
12.3 Mylan
12.3.1 Mylan Company Information
12.3.2 Mylan Injectable Suspension Budesonide Product Offered
12.3.3 Mylan Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mylan Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Sandoz
12.4.1 Sandoz Company Information
12.4.2 Sandoz Injectable Suspension Budesonide Product Offered
12.4.3 Sandoz Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sandoz Main Business Overview
12.4.5 Sandoz Latest Developments
12.5 Cosmo Pharmaceuticals
12.5.1 Cosmo Pharmaceuticals Company Information
12.5.2 Cosmo Pharmaceuticals Injectable Suspension Budesonide Product Offered
12.5.3 Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Cosmo Pharmaceuticals Main Business Overview
12.5.5 Cosmo Pharmaceuticals Latest Developments
12.6 Salix
12.6.1 Salix Company Information
12.6.2 Salix Injectable Suspension Budesonide Product Offered
12.6.3 Salix Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Salix Main Business Overview
12.6.5 Salix Latest Developments
12.7 Chiesi Farmaceutici
12.7.1 Chiesi Farmaceutici Company Information
12.7.2 Chiesi Farmaceutici Injectable Suspension Budesonide Product Offered
12.7.3 Chiesi Farmaceutici Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Chiesi Farmaceutici Main Business Overview
12.7.5 Chiesi Farmaceutici Latest Developments
12.8 Orion Corporation
12.8.1 Orion Corporation Company Information
12.8.2 Orion Corporation Injectable Suspension Budesonide Product Offered
12.8.3 Orion Corporation Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Orion Corporation Main Business Overview
12.8.5 Orion Corporation Latest Developments
12.9 Cipla
12.9.1 Cipla Company Information
12.9.2 Cipla Injectable Suspension Budesonide Product Offered
12.9.3 Cipla Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Cipla Main Business Overview
12.9.5 Cipla Latest Developments
12.10 Synmosa Biopharma
12.10.1 Synmosa Biopharma Company Information
12.10.2 Synmosa Biopharma Injectable Suspension Budesonide Product Offered
12.10.3 Synmosa Biopharma Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Synmosa Biopharma Main Business Overview
12.10.5 Synmosa Biopharma Latest Developments
12.11 Lunan Better Pharma
12.11.1 Lunan Better Pharma Company Information
12.11.2 Lunan Better Pharma Injectable Suspension Budesonide Product Offered
12.11.3 Lunan Better Pharma Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Lunan Better Pharma Main Business Overview
12.11.5 Lunan Better Pharma Latest Developments
12.12 Shanghai Sine Promod
12.12.1 Shanghai Sine Promod Company Information
12.12.2 Shanghai Sine Promod Injectable Suspension Budesonide Product Offered
12.12.3 Shanghai Sine Promod Injectable Suspension Budesonide Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Shanghai Sine Promod Main Business Overview
12.12.5 Shanghai Sine Promod Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Injectable Suspension Budesonide Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 0.5mg
Table 3. Major Players of 1mg
Table 4. Global Injectable Suspension Budesonide Sales by Type (2016-2021) & (K Units)
Table 5. Global Injectable Suspension Budesonide Sales Market Share by Type (2016-2021)
Table 6. Global Injectable Suspension Budesonide Revenue by Type (2016-2021) & ($ million)
Table 7. Global Injectable Suspension Budesonide Revenue Market Share by Type (2016-2021)
Table 8. Global Injectable Suspension Budesonide Sale Price by Type (2016-2021)
Table 9. Global Injectable Suspension Budesonide Sales by Application (2016-2021) & (K Units)
Table 10. Global Injectable Suspension Budesonide Sales Market Share by Application (2016-2021)
Table 11. Global Injectable Suspension Budesonide Value by Application (2016-2021)
Table 12. Global Injectable Suspension Budesonide Revenue Market Share by Application (2016-2021)
Table 13. Global Injectable Suspension Budesonide Sale Price by Application (2016-2021)
Table 14. Global Injectable Suspension Budesonide Sales by Company (2019-2021) & (K Units)
Table 15. Global Injectable Suspension Budesonide Sales Market Share by Company (2019-2021)
Table 16. Global Injectable Suspension Budesonide Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Injectable Suspension Budesonide Revenue Market Share by Company (2019-2021)
Table 18. Global Injectable Suspension Budesonide Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Injectable Suspension Budesonide Producing Area Distribution and Sales Area
Table 20. Players Injectable Suspension Budesonide Products Offered
Table 21. Injectable Suspension Budesonide Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Injectable Suspension Budesonide Sales by Region (2016-2021) (K Units)
Table 25. Global Injectable Suspension Budesonide Sales Market Share by Region (2016-2021)
Table 26. Global Injectable Suspension Budesonide Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Injectable Suspension Budesonide Revenue Market Share by Region (2016-2021)
Table 28. Americas Injectable Suspension Budesonide Sales by Country (2016-2021) & (K Units)
Table 29. Americas Injectable Suspension Budesonide Sales Market Share by Country (2016-2021)
Table 30. Americas Injectable Suspension Budesonide Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Injectable Suspension Budesonide Revenue Market Share by Country (2016-2021)
Table 32. Americas Injectable Suspension Budesonide Sales by Type (2016-2021) & (K Units)
Table 33. Americas Injectable Suspension Budesonide Sales Market Share by Type (2016-2021)
Table 34. Americas Injectable Suspension Budesonide Sales by Application (2016-2021) & (K Units)
Table 35. Americas Injectable Suspension Budesonide Sales Market Share by Application (2016-2021)
Table 36. APAC Injectable Suspension Budesonide Sales by Region (2016-2021) & (K Units)
Table 37. APAC Injectable Suspension Budesonide Sales Market Share by Region (2016-2021)
Table 38. APAC Injectable Suspension Budesonide Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Injectable Suspension Budesonide Revenue Market Share by Region (2016-2021)
Table 40. APAC Injectable Suspension Budesonide Sales by Type (2016-2021) & (K Units)
Table 41. APAC Injectable Suspension Budesonide Sales Market Share by Type (2016-2021)
Table 42. APAC Injectable Suspension Budesonide Sales by Application (2016-2021) & (K Units)
Table 43. APAC Injectable Suspension Budesonide Sales Market Share by Application (2016-2021)
Table 44. Europe Injectable Suspension Budesonide Sales by Country (2016-2021) & (K Units)
Table 45. Europe Injectable Suspension Budesonide Sales Market Share by Country (2016-2021)
Table 46. Europe Injectable Suspension Budesonide Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Injectable Suspension Budesonide Revenue Market Share by Country (2016-2021)
Table 48. Europe Injectable Suspension Budesonide Sales by Type (2016-2021) & (K Units)
Table 49. Europe Injectable Suspension Budesonide Sales Market Share by Type (2016-2021)
Table 50. Europe Injectable Suspension Budesonide Sales by Application (2016-2021) & (K Units)
Table 51. Europe Injectable Suspension Budesonide Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Injectable Suspension Budesonide Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Injectable Suspension Budesonide Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Injectable Suspension Budesonide Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Injectable Suspension Budesonide Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Injectable Suspension Budesonide Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Injectable Suspension Budesonide Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Injectable Suspension Budesonide Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Injectable Suspension Budesonide Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Injectable Suspension Budesonide
Table 61. Key Application and Potential Industries of Injectable Suspension Budesonide
Table 62. Key Challenges of Injectable Suspension Budesonide
Table 63. Key Trends of Injectable Suspension Budesonide
Table 64. Injectable Suspension Budesonide Distributors List
Table 65. Injectable Suspension Budesonide Customer List
Table 66. Global Injectable Suspension Budesonide Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Injectable Suspension Budesonide Consumption Market Forecast by Region
Table 68. Global Injectable Suspension Budesonide Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Injectable Suspension Budesonide Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Injectable Suspension Budesonide Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Injectable Suspension Budesonide Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Injectable Suspension Budesonide Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Injectable Suspension Budesonide Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Injectable Suspension Budesonide Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Injectable Suspension Budesonide Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Injectable Suspension Budesonide Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Injectable Suspension Budesonide Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Injectable Suspension Budesonide Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Injectable Suspension Budesonide Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Injectable Suspension Budesonide Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Injectable Suspension Budesonide Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Injectable Suspension Budesonide Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Injectable Suspension Budesonide Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Injectable Suspension Budesonide Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Injectable Suspension Budesonide Revenue Market Share Forecast by Application (2021-2026)
Table 86. AstraZeneca Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 87. AstraZeneca Injectable Suspension Budesonide Product Offered
Table 88. AstraZeneca Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. AstraZeneca Main Business
Table 90. AstraZeneca Latest Developments
Table 91. Teva Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 92. Teva Injectable Suspension Budesonide Product Offered
Table 93. Teva Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Teva Main Business
Table 95. Teva Latest Developments
Table 96. Mylan Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 97. Mylan Injectable Suspension Budesonide Product Offered
Table 98. Mylan Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. Mylan Main Business
Table 100. Mylan Latest Developments
Table 101. Sandoz Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 102. Sandoz Injectable Suspension Budesonide Product Offered
Table 103. Sandoz Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Sandoz Main Business
Table 105. Sandoz Latest Developments
Table 106. Cosmo Pharmaceuticals Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 107. Cosmo Pharmaceuticals Injectable Suspension Budesonide Product Offered
Table 108. Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Cosmo Pharmaceuticals Main Business
Table 110. Cosmo Pharmaceuticals Latest Developments
Table 111. Salix Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 112. Salix Injectable Suspension Budesonide Product Offered
Table 113. Salix Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Salix Main Business
Table 115. Salix Latest Developments
Table 116. Chiesi Farmaceutici Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 117. Chiesi Farmaceutici Injectable Suspension Budesonide Product Offered
Table 118. Chiesi Farmaceutici Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Chiesi Farmaceutici Main Business
Table 120. Chiesi Farmaceutici Latest Developments
Table 121. Orion Corporation Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 122. Orion Corporation Injectable Suspension Budesonide Product Offered
Table 123. Orion Corporation Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Orion Corporation Main Business
Table 125. Orion Corporation Latest Developments
Table 126. Cipla Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 127. Cipla Injectable Suspension Budesonide Product Offered
Table 128. Cipla Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. Cipla Main Business
Table 130. Cipla Latest Developments
Table 131. Synmosa Biopharma Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 132. Synmosa Biopharma Injectable Suspension Budesonide Product Offered
Table 133. Synmosa Biopharma Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. Synmosa Biopharma Main Business
Table 135. Synmosa Biopharma Latest Developments
Table 136. Lunan Better Pharma Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 137. Lunan Better Pharma Injectable Suspension Budesonide Product Offered
Table 138. Lunan Better Pharma Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 139. Lunan Better Pharma Main Business
Table 140. Lunan Better Pharma Latest Developments
Table 141. Shanghai Sine Promod Basic Information, Injectable Suspension Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 142. Shanghai Sine Promod Injectable Suspension Budesonide Product Offered
Table 143. Shanghai Sine Promod Injectable Suspension Budesonide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 144. Shanghai Sine Promod Main Business
Table 145. Shanghai Sine Promod Latest Developments
List of Figures
Figure 1. Picture of Injectable Suspension Budesonide
Figure 2. Injectable Suspension Budesonide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Suspension Budesonide Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Injectable Suspension Budesonide Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Injectable Suspension Budesonide Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 0.5mg
Figure 10. Product Picture of 1mg
Figure 11. Global Injectable Suspension Budesonide Sales Market Share by Type in 2020
Figure 12. Global Injectable Suspension Budesonide Revenue Market Share by Type (2016-2021)
Figure 13. Injectable Suspension Budesonide Consumed in Respiratory Disease Treatment
Figure 14. Global Injectable Suspension Budesonide Market: Respiratory Disease Treatment (2016-2021) & (K Units)
Figure 15. Injectable Suspension Budesonide Consumed in Nose Disease Treatment
Figure 16. Global Injectable Suspension Budesonide Market: Nose Disease Treatment (2016-2021) & (K Units)
Figure 17. Injectable Suspension Budesonide Consumed in Inflammatory Bowel Disease Treatment
Figure 18. Global Injectable Suspension Budesonide Market: Inflammatory Bowel Disease Treatment (2016-2021) & (K Units)
Figure 19. Injectable Suspension Budesonide Consumed in Other
Figure 20. Global Injectable Suspension Budesonide Market: Other (2016-2021) & (K Units)
Figure 21. Global Injectable Suspension Budesonide Sales Market Share by Application (2016-2021)
Figure 22. Global Injectable Suspension Budesonide Revenue Market Share by Application in 2020
Figure 23. Injectable Suspension Budesonide Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Injectable Suspension Budesonide Revenue Market Share by Company in 2020
Figure 25. Global Injectable Suspension Budesonide Sales Market Share by Regions (2016-2021)
Figure 26. Global Injectable Suspension Budesonide Revenue Market Share by Region in 2020
Figure 27. Americas Injectable Suspension Budesonide Sales 2016-2021 (K Units)
Figure 28. Americas Injectable Suspension Budesonide Revenue 2016-2021 ($ Millions)
Figure 29. APAC Injectable Suspension Budesonide Sales 2016-2021 (K Units)
Figure 30. APAC Injectable Suspension Budesonide Revenue 2016-2021 ($ Millions)
Figure 31. Europe Injectable Suspension Budesonide Sales 2016-2021 (K Units)
Figure 32. Europe Injectable Suspension Budesonide Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Injectable Suspension Budesonide Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Injectable Suspension Budesonide Revenue 2016-2021 ($ Millions)
Figure 35. Americas Injectable Suspension Budesonide Sales Market Share by Country in 2020
Figure 36. Americas Injectable Suspension Budesonide Revenue Market Share by Country in 2020
Figure 37. Americas Injectable Suspension Budesonide Sales Market Share by Type in 2020
Figure 38. Americas Injectable Suspension Budesonide Sales Market Share by Application in 2020
Figure 39. United States Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Injectable Suspension Budesonide Sales Market Share by Region in 2020
Figure 44. APAC Injectable Suspension Budesonide Revenue Market Share by Regions in 2020
Figure 45. APAC Injectable Suspension Budesonide Sales Market Share by Type in 2020
Figure 46. APAC Injectable Suspension Budesonide Sales Market Share by Application in 2020
Figure 47. China Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Injectable Suspension Budesonide Sales Market Share by Country in 2020
Figure 54. Europe Injectable Suspension Budesonide Revenue Market Share by Country in 2020
Figure 55. Europe Injectable Suspension Budesonide Sales Market Share by Type in 2020
Figure 56. Europe Injectable Suspension Budesonide Sales Market Share by Application in 2020
Figure 57. Germany Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Injectable Suspension Budesonide Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Injectable Suspension Budesonide Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Injectable Suspension Budesonide Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Injectable Suspension Budesonide Sales Market Share by Application in 2020
Figure 66. Egypt Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Injectable Suspension Budesonide Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の注射用懸濁液ブデソニド市場予測 2021年-2026年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆